Labcorp Secures $750 Million Term Loan for General Corporate Purposes
LH sits 26% above its 52-week low of $209.375.
Summary
Labcorp Holdings Inc. and its subsidiary secured a new $750 million senior unsecured term loan, fully funded today, to be used for general corporate purposes.
Key Events · Financing and Capital Events · LH
-
Secured New Term Loan
Labcorp Holdings Inc. and its subsidiary, Laboratory Corporation of America Holdings, entered into a $750 million senior unsecured term loan credit agreement.
-
Immediate Funding
The full $750 million term loan was funded on the closing date, March 20, 2026.
-
Maturity and Interest
The loan matures on March 20, 2028, and bears interest at a floating rate (SOFR-based rate + 0.700% or base rate + 0%).
-
Use of Proceeds
Proceeds are designated for general corporate purposes of the Parent and its Subsidiaries, and to cover transaction fees and expenses.
Analysis · LH · Industrial Applications And Services
This 8-K announces a significant financing event for Labcorp, securing $750 million through a new term loan. This capital infusion provides substantial liquidity for general corporate purposes, enhancing the company's financial flexibility and operational runway. While increasing the company's debt, the loan's terms, including a floating interest rate and a leverage ratio covenant of 4.0:1.0 (with a temporary increase to 4.5:1.0 for material acquisitions), appear standard for a company of Labcorp's size. This move suggests the company is proactively managing its capital structure and ensuring resources for ongoing operations and potential strategic initiatives.
At the time of this filing, LH was trading at $263.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $21.7B. The 52-week trading range was $209.38 to $293.72. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.